The ability of laser-driven TRPV2–PCNH nanoparticles to regulate cancer stemness was evaluated via immunohistochemistry staining of Ki-67 and CD133, which are proliferation and stem cell markers, respectively. The gene discussed is PROM1; the disease is cancer.